1
|
Loibl S, Azim HA, Bachelot T, Berveiller P, Bosch A, Cardonick E, Denkert C, Halaska MJ, Hoeltzenbein M, Johansson ALV, Maggen C, Markert UR, Peccatori F, Poortmans P, Saloustros E, Saura C, Schmid P, Stamatakis E, van den Heuvel-Eibrink M, van Gerwen M, Vandecaveye V, Pentheroudakis G, Curigliano G, Amant F. ESMO Expert Consensus Statements on the management of breast cancer during pregnancy (PrBC). Ann Oncol 2023; 34:849-866. [PMID: 37572987 DOI: 10.1016/j.annonc.2023.08.001] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/03/2023] [Revised: 07/31/2023] [Accepted: 08/01/2023] [Indexed: 08/14/2023] Open
Abstract
The management of breast cancer during pregnancy (PrBC) is a relatively rare indication and an area where no or little evidence is available since randomized controlled trials cannot be conducted. In general, advances related to breast cancer (BC) treatment outside pregnancy cannot always be translated to PrBC, because both the interests of the mother and of the unborn should be considered. Evidence remains limited and/or conflicting in some specific areas where the optimal approach remains controversial. In 2022, the European Society for Medical Oncology (ESMO) held a virtual consensus-building process on this topic to gain insights from a multidisciplinary group of experts and develop statements on controversial topics that cannot be adequately addressed in the current evidence-based ESMO Clinical Practice Guideline. The aim of this consensus-building process was to discuss controversial issues relating to the management of patients with PrBC. The virtual meeting included a multidisciplinary panel of 24 leading experts from 13 countries and was chaired by S. Loibl and F. Amant. All experts were allocated to one of four different working groups. Each working group covered a specific subject area with two chairs appointed: Planning, preparation and execution of the consensus process was conducted according to the ESMO standard operating procedures.
Collapse
Affiliation(s)
- S Loibl
- GBG c/o GBG Forschungs GmbH, Neu-Isenburg; Centre for Haematology and Oncology Bethanien, Frankfurt am Main, Frankfurt; Goethe University Frankfurt, Frankfurt am Main, Frankfurt, Germany.
| | - H A Azim
- Breast Cancer Center, School of Medicine, Tecnologico de Monterrey, San Pedro Garza Garcia, Nuevo Leon, Mexico
| | - T Bachelot
- Department of medical oncology, Centre Léon Bérard, Lyon, France
| | - P Berveiller
- Department of Gynecology and Obstetrics, Poissy-Saint Germain Hospital, Poissy; UMR 1198 - BREED, INRAE, Paris Saclay University, RHuMA, Montigny-Le-Bretonneux, France
| | - A Bosch
- Division of Oncology, Department of Clinical Sciences, Lund University, Lund; Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden
| | - E Cardonick
- Cooper Medical School at Rowan University, Camden, USA
| | - C Denkert
- Philipps-University Marburg and Marburg University Hospital (UKGM), Marburg, Germany
| | - M J Halaska
- Department of Obstetrics and Gynaecology, Third Faculty of Medicine, Charles University in Prague and Universital Hospital Kralovske Vinohrady, Prague, Czech Republic
| | - M Hoeltzenbein
- Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Clinical Pharmacology and Toxicology, Embryotox Center of Clinical Teratology and Drug Safety in Pregnancy, Berlin, Germany
| | - A L V Johansson
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; Cancer Registry of Norway, Oslo, Norway
| | - C Maggen
- Department of Obstetrics and Prenatal Medicine, University Hospital Brussels, Brussels, Belgium
| | - U R Markert
- Placenta Lab, Department of Obstetrics, Jena University Hospital, Jena, Germany
| | - F Peccatori
- Gynecologic Oncology Department, European Institute of Oncology IRCCS, Milan, Italy
| | - P Poortmans
- Iridium Netwerk, Antwerp; University of Antwerp, Antwerp, Belgium
| | - E Saloustros
- Department of Oncology, University General Hospital of Larissa, Larissa, Greece
| | - C Saura
- Medical Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain
| | - P Schmid
- Cancer Institute, Queen Mary University London, London, UK
| | - E Stamatakis
- Department of Anesthesiology, 'Alexandra' General Hospital, Athens, Greece
| | | | - M van Gerwen
- Gynecologic Oncology, Antoni van Leeuwenhoek-Netherlands Cancer Institute, Amsterdam; Department of Child and Adolescent Psychiatry and Psychosocial Care, Amsterdam UMC, University of Amsterdam; Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands
| | - V Vandecaveye
- Department of Radiology, University Hospitals Leuven, Leuven, Belgium
| | - G Pentheroudakis
- European Society for Medical Oncology (ESMO), Lugano, Switzerland
| | - G Curigliano
- Division of Early Drug Development, European Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy
| | - F Amant
- Gynecologic Oncology, Antoni van Leeuwenhoek-Netherlands Cancer Institute, Amsterdam; Division Gynaecologic Oncology, UZ Leuven, Belgium
| |
Collapse
|
2
|
Pastuschek J, Bär C, Göhner C, Budde U, Leidenmuehler P, Groten T, Schleußner E, Markert UR. Ex vivo human placental transfer study on recombinant Von Willebrand factor (rVWF). Placenta 2021; 111:69-75. [PMID: 34171523 DOI: 10.1016/j.placenta.2021.05.010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/22/2020] [Revised: 04/29/2021] [Accepted: 05/31/2021] [Indexed: 10/21/2022]
Abstract
Deficiency or mutation of von Willebrand factor (VWF) leads to a coagulation disorder (von Willebrand disease; VWD) which requires a lifelong therapy. For avoiding maternal complications treatment may be necessary also in pregnancy, but placental transfer to the fetus might impact its coagulation system and evoke undesired side effects. As VWF is a very large molecule it may be assumed that it does not pass the placental barrier. To prove this hypothesis the materno-fetal transfer of recombinant VWF (rVWF) has been analyzed ex vivo in a total of 21 valid dual side placenta perfusions. Three groups of five placentas each have been perfused with physiological and up to ten-fold increased concentrations of rVWF for 2 h. Six placentas have been used for control perfusions. A series of different control parameters has been assessed for documentation of intactness and functionality of the placenta and the perfusion system. In not a single analysis, independent of time and concentration, rVWF was detected in the fetal circuit. In the maternal circuit VWF concentration decreased slightly during perfusion. These results demonstrate that recombinant VWF does not pass the human placenta.
Collapse
Affiliation(s)
- J Pastuschek
- Placenta Lab, Department of Obstetrics, University Hospital Jena, Am Klinikum 1, 07747, Jena, Germany
| | - C Bär
- Placenta Lab, Department of Obstetrics, University Hospital Jena, Am Klinikum 1, 07747, Jena, Germany
| | - C Göhner
- Placenta Lab, Department of Obstetrics, University Hospital Jena, Am Klinikum 1, 07747, Jena, Germany
| | - U Budde
- Medilys Laborgesellschaft MbH, Paul-Ehrlich-Str. 1, 22763, Hamburg, Germany
| | | | - T Groten
- Placenta Lab, Department of Obstetrics, University Hospital Jena, Am Klinikum 1, 07747, Jena, Germany
| | - E Schleußner
- Placenta Lab, Department of Obstetrics, University Hospital Jena, Am Klinikum 1, 07747, Jena, Germany
| | - U R Markert
- Placenta Lab, Department of Obstetrics, University Hospital Jena, Am Klinikum 1, 07747, Jena, Germany.
| |
Collapse
|
3
|
Brummer C, Markert U, Schleußner E, Groten T. Die plazentare Histopathologie bei Risikoschwangerschaften. Geburtshilfe Frauenheilkd 2020. [DOI: 10.1055/s-0040-1717925] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
Affiliation(s)
- C Brummer
- Universitätsklinikum Jena, Klinik für Geburtsmedizin
| | - U Markert
- Universitätsklinikum Jena, Klinik für Geburtsmedizin
| | - E Schleußner
- Universitätsklinikum Jena, Klinik für Geburtsmedizin
| | - T Groten
- Universitätsklinikum Jena, Klinik für Geburtsmedizin
| |
Collapse
|
4
|
Vomstein K, Kuon RJ, Weber M, Markert U, Strowitzki T, Toth B. Prevalence of CD138+ uterine plasma cells and CD56-positive uterine NK-cells in patients with recurrent miscarriage. Geburtshilfe Frauenheilkd 2018. [DOI: 10.1055/s-0038-1671287] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022] Open
Affiliation(s)
- K Vomstein
- Medizinische Universität Innsbruck, Gynäkologische Endokrinologie und Reproduktionsmedizin, Innsbruck, Österreich
- Universitärtsklinikum Heidelberg, Gynäkologische Endokrinologie und Fertilitätsstörungen, Heidelberg, Deutschland
| | - RJ Kuon
- Universitärtsklinikum Heidelberg, Gynäkologische Endokrinologie und Fertilitätsstörungen, Heidelberg, Deutschland
| | - M Weber
- Universitätsklinikum Jena, Klinik für Geburtsmedizin, Plazentalabor, Jena, Deutschland
| | - U Markert
- Universitätsklinikum Jena, Klinik für Geburtsmedizin, Plazentalabor, Jena, Deutschland
| | - T Strowitzki
- Universitärtsklinikum Heidelberg, Gynäkologische Endokrinologie und Fertilitätsstörungen, Heidelberg, Deutschland
| | - B Toth
- Medizinische Universität Innsbruck, Gynäkologische Endokrinologie und Reproduktionsmedizin, Innsbruck, Österreich
| |
Collapse
|
5
|
Markert UR, Pastuschek J, Heger JI, Favaro R, Bär C, Weber M, Kuon RJ, Toth B, Schleußner E. Natürliche Killerzellen und Plasmazellen im Endometrium bei Patientinnen mit unerfülltem Kinderwunsch. Geburtshilfe Frauenheilkd 2018. [DOI: 10.1055/s-0038-1670987] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022] Open
Affiliation(s)
- UR Markert
- Universitätsklinikum Jena, Klinik für Geburtsmedizin, Placenta-Labor, Jena, Deutschland
| | - J Pastuschek
- Universitätsklinikum Jena, Klinik für Geburtsmedizin, Placenta-Labor, Jena, Deutschland
| | - JI Heger
- Universitätsklinikum Jena, Klinik für Geburtsmedizin, Placenta-Labor, Jena, Deutschland
| | - R Favaro
- Universitätsklinikum Jena, Klinik für Geburtsmedizin, Placenta-Labor, Jena, Deutschland
| | - C Bär
- Universitätsklinikum Jena, Klinik für Geburtsmedizin, Placenta-Labor, Jena, Deutschland
| | - M Weber
- Universitätsklinikum Jena, Klinik für Geburtsmedizin, Placenta-Labor, Jena, Deutschland
| | - RJ Kuon
- Universitätsklinikum Heidelberg, Abteilung für Gynäkologische Endokrinologie und Fertilitätsstörungen, Heidelberg, Deutschland
| | - B Toth
- Tirol Kliniken Innsbruck, Universitätsklinik für Gynäkologische Endokrinologie und Reproduktionsmedizin, Innsbruck, Österreich
| | - E Schleußner
- Universitätsklinikum Jena, Klinik für Geburtsmedizin, Placenta-Labor, Jena, Deutschland
| |
Collapse
|
6
|
Teichert V, Schleußner E, Markert U, Groten T. Untersuchungen zur Wirkung von Pentaerythrityltetranitrat (PETN) auf die Dysfunktion von Endothelzellmonolayern. Geburtshilfe Frauenheilkd 2018. [DOI: 10.1055/s-0038-1671154] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022] Open
Affiliation(s)
- V Teichert
- Universitätsklinikum Jena, Placentalabor, Klinik für Geburtsmedizin, Jena, Deutschland
| | - E Schleußner
- Universitätsklinikum Jena, Geburtshilfe, Jena, Deutschland
| | - U Markert
- Universitätsklinikum Jena, Placentalabor, Klinik für Geburtsmedizin, Jena, Deutschland
| | - T Groten
- Universitätsklinikum Jena, Klinik für Geburtsmedizin, Jena, Deutschland
| |
Collapse
|
7
|
Vomstein K, Markert U, Weber M, Strowitzki T, Toth B, Kuon R. Prevalence of CD138+ uterine plasma cells and CD56-positive uterine NK-cells in patients with recurrent miscarriage. J Reprod Immunol 2018. [DOI: 10.1016/j.jri.2018.06.028] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
8
|
Markert UR, Pastuschek J, Heger JI, Favaro R, Bär C, Weber M, Kuon RJ, Toth B, Schleußner E. Natürliche Killerzellen und Plasmazellen im Endometrium bei Patientinnen mit unerfülltem Kinderwunsch. Geburtshilfe Frauenheilkd 2018. [DOI: 10.1055/s-0038-1660654] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022] Open
Affiliation(s)
- UR Markert
- Placenta-Labor, Klinik für Geburtsmedizin, Universitätsklinikum Jena
| | - J Pastuschek
- Placenta-Labor, Klinik für Geburtsmedizin, Universitätsklinikum Jena
| | - JI Heger
- Placenta-Labor, Klinik für Geburtsmedizin, Universitätsklinikum Jena
| | - R Favaro
- Placenta-Labor, Klinik für Geburtsmedizin, Universitätsklinikum Jena
| | - C Bär
- Placenta-Labor, Klinik für Geburtsmedizin, Universitätsklinikum Jena
| | - M Weber
- Placenta-Labor, Klinik für Geburtsmedizin, Universitätsklinikum Jena
| | - RJ Kuon
- Abteilung für Gynäkologische Endokrinologie und Fertilitätsstörungen, Universitätsklinikum Heidelberg
| | - B Toth
- Universitätsklinik für Gynäkologische Endokrinologie und Reproduktionsmedizin, Tirol Kliniken Innsbruck
| | - E Schleußner
- Placenta-Labor, Klinik für Geburtsmedizin, Universitätsklinikum Jena
| |
Collapse
|
9
|
Markert UR, Pastuschek J, Heger JI, Favaro R, Bär C, Weber M, Kuon RJ, Toth B, Schleußner E. Natürliche Killerzellen und Plasmazellen im Endometrium bei Patientinnen mit unerfülltem Kinderwunsch. Geburtshilfe Frauenheilkd 2018. [DOI: 10.1055/s-0038-1645891] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
Affiliation(s)
- UR Markert
- Placenta-Labor, Klinik für Geburtsmedizin, Universitätsklinikum Jena
| | - J Pastuschek
- Placenta-Labor, Klinik für Geburtsmedizin, Universitätsklinikum Jena
| | - JI Heger
- Placenta-Labor, Klinik für Geburtsmedizin, Universitätsklinikum Jena
| | - R Favaro
- Placenta-Labor, Klinik für Geburtsmedizin, Universitätsklinikum Jena
| | - C Bär
- Placenta-Labor, Klinik für Geburtsmedizin, Universitätsklinikum Jena
| | - M Weber
- Placenta-Labor, Klinik für Geburtsmedizin, Universitätsklinikum Jena
| | - RJ Kuon
- Abteilung für Gynäkologische Endokrinologie und Fertilitätsstörungen, Universitätsklinikum Heidelberg
| | - B Toth
- Universitätsklinik für Gynäkologische Endokrinologie und Reproduktionsmedizin, Tirol Kliniken Innsbruck
| | - E Schleußner
- Placenta-Labor, Klinik für Geburtsmedizin, Universitätsklinikum Jena
| |
Collapse
|
10
|
Johnson S, Pastuschek J, Groten T, Rödel J, Sammer U, Markert U. Plazenta als Heilmittel – Chancen und Risiken. Geburtshilfe Frauenheilkd 2018. [DOI: 10.1055/s-0038-1645939] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
Affiliation(s)
- S Johnson
- Placenta-Labor, Klinik für Geburtsmedizin, Universitätsklinikum Jena
| | - J Pastuschek
- Placenta-Labor, Klinik für Geburtsmedizin, Universitätsklinikum Jena
| | - T Groten
- Placenta-Labor, Klinik für Geburtsmedizin, Universitätsklinikum Jena
| | - J Rödel
- Institut für klinische Mikrobiologie, Universitätsklinikum Jena
| | - U Sammer
- Food GmbH, Analytik & Consulting, Jena
| | - U Markert
- Placenta-Labor, Klinik für Geburtsmedizin, Universitätsklinikum Jena
| |
Collapse
|
11
|
Multhaup A, Huppertz B, Göhner C, Böhringer M, Mai M, Markert U, Schleußner E, Groten T. N-cadherin knockdown leads to disruption of trophoblastic and endothelial cell interaction in a 3D cell culture model - New insights in trophoblast invasion failure. Cell Adh Migr 2017; 12:259-270. [PMID: 29231798 DOI: 10.1080/19336918.2017.1386822] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022] Open
Abstract
INTRODUCTION Trophoblast homing to maternal spiral arteries is mandatory for successful placentation. Cell-cell adhesion molecules regulate this process and adhesion molecule expression is altered in impaired placentation. We hypothesize that, similar to immune cell recruitment, trophoblast cell adherence and rolling are primarily mediated by adhesion molecules like, cadherins, immunoglobulins, selectins and their partnering ligands. Here, the interdependence of adhesion molecule expression in trophoblastic cell lines of diverse origin was investigated in relation to their interaction with endothelial cell networks on Matrigel® co-cultures and the effect of specific adhesion molecule knockdown analyzed. METHODS Trophoblastic cells were labeled in red and co-cultured with green HUVEC networks on Matrigel®. Association was quantified after collection of fluorescence microscopy pictures using Wimasis® internet platform and software. Expression of adhesion molecules was analyzed by PCR and Western blot, immuno-fluorescence and flow cytometry. The impact of adhesion molecules on trophoblast-endothelial-cell interaction was investigated using siRNA technique. RESULTS N-cadherin and CD162 were specifically expressed in the trophoblast cell line HTR-8/SVneo, which closely adhere to and actively migrate toward HUVEC networks on Matrigel®. Suppression of N-cadherin led to a significant alteration in trophoblast-endothelial cell interaction. Expression of VE-cadherin in closely interacting trophoblast cells was not confirmed in vitro. DISCUSSION We identified N-cadherin to mediate specific interaction between HUVEC and the migrating trophoblast cells HTR-8/SVneo in a Matrigel® co-culture model. VE-cadherin contribution could not be confirmed in vitro. Our results support the hypothesis that impaired N-cadherin but not VE-cadherin expression is involved in trophoblast recruitment to the maternal endothelium.
Collapse
Affiliation(s)
- A Multhaup
- a Department of Obstetrics , University Hospital Jena, Friedrich-Schiller-University , Jena , Germany
| | - B Huppertz
- b Institute of Cell Biology, Histology and Embryology, Medical University Graz , Graz, Austria
| | - C Göhner
- a Department of Obstetrics , University Hospital Jena, Friedrich-Schiller-University , Jena , Germany
| | - M Böhringer
- c Septomics Research Centre, Friedrich Schiller University and Leibniz Institute for Natural Product Research and Infection Biology - Hans Knöll Institute , Jena , Germany
| | - M Mai
- a Department of Obstetrics , University Hospital Jena, Friedrich-Schiller-University , Jena , Germany
| | - U Markert
- a Department of Obstetrics , University Hospital Jena, Friedrich-Schiller-University , Jena , Germany
| | - E Schleußner
- a Department of Obstetrics , University Hospital Jena, Friedrich-Schiller-University , Jena , Germany
| | - T Groten
- a Department of Obstetrics , University Hospital Jena, Friedrich-Schiller-University , Jena , Germany
| |
Collapse
|
12
|
Heger J, Fröhlich K, Schmidt A, Markert UR. Plazenta-Explantate als Modell für toxikologische Analysen. Geburtshilfe Frauenheilkd 2017. [DOI: 10.1055/s-0037-1601531] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022] Open
Affiliation(s)
- J Heger
- Universitätsklinikum Jena, Klinik für Geburtsmedizin, Placenta-Labor
| | - K Fröhlich
- Universitätsklinikum Jena, Klinik für Geburtsmedizin, Placenta-Labor
| | - A Schmidt
- Universitätsklinikum Jena, Klinik für Geburtsmedizin, Placenta-Labor
| | - UR Markert
- Universitätsklinikum Jena, Klinik für Geburtsmedizin, Placenta-Labor
| |
Collapse
|
13
|
Fröhlich K, Morgner S, Hauswald L, Heger J, Markert UR. Erwünschte und unerwünschte Effekte von Chemotherapeutika auf Mammakarzinom- und Trophoblast-Sphäroide. Geburtshilfe Frauenheilkd 2017. [DOI: 10.1055/s-0037-1601549] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022] Open
Affiliation(s)
- K Fröhlich
- Placenta-Labor, Klinik für Geburtsmedizin, Universitätsklinikum Jena
| | - S Morgner
- Placenta-Labor, Klinik für Geburtsmedizin, Universitätsklinikum Jena
| | - L Hauswald
- Placenta-Labor, Klinik für Geburtsmedizin, Universitätsklinikum Jena
| | - J Heger
- Placenta-Labor, Klinik für Geburtsmedizin, Universitätsklinikum Jena
| | - UR Markert
- Placenta-Labor, Klinik für Geburtsmedizin, Universitätsklinikum Jena
| |
Collapse
|
14
|
Kuon RJ, Togawa R, Vomstein K, Weber M, Goeggl T, Strowitzki T, Markert UR, Zimmermann S, Daniel V, Dalpke AH, Toth B. Higher prevalence of colonization with Gardnerella vaginalis and gram-negative anaerobes in patients with recurrent miscarriage and elevated peripheral natural killer cells. J Reprod Immunol 2017; 120:15-19. [PMID: 28388469 DOI: 10.1016/j.jri.2017.03.001] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/30/2016] [Revised: 03/19/2017] [Accepted: 03/24/2017] [Indexed: 11/29/2022]
Abstract
The role of vaginal infections in recurrent miscarriage (RM) is discussed controversially and screening is not recommended in international guidelines. Peripheral and uterine NK cells (pNK, uNK) play an important role in the establishment of a healthy pregnancy and are targets of immune diagnostics in RM patients. The aim of this study was to analyze the composition of the vaginal microbiota in RM patients and to correlate the findings to clinical characteristics as well as NK cell parameters. In total, n=243 RM patients with ≥3 consecutive miscarriages were recruited between 11/2011 and 03/2016. Vaginal swabs were analyzed by microbiological culture. Further, a cervical swab was taken in n=187 patients and the presence of Chlamydia trachomatis was evaluated by a molecular assay. Peripheral blood levels of CD45+CD3-CD56+CD16+ pNK (determined by four-color fluorescence flow cytometry) and CD56+ uNK (uterine biopsy, determined by immunohistochemistry) were analyzed. The prevalence of Gardnerella vaginalis colonization in RM patients was 19.0%, gram-negative anaerobes 20.5%, Candida species 7.9%, group B Streptococcus 11.0% and Enterobacteriaceae 14.8%. Commensal lactobacilli were absent in 14.5% of the women. Chlamydia trachomatis was detected in n=1 case (0.53%). The prevalence of Gardnerella vaginalis and gram-negative anaerobes in RM patients with elevated pNK (>280/μl, n=69) was significantly higher (p=0.012, p=0.04) compared to patients with normal pNK (n=174). In conclusion, RM patients with elevated pNK suffer more often from colonization by Gardnerella vaginalis and gram-negative anaerobes. This might indicate an association between the vaginal microbiota, local inflammation, changes in immune parameters and miscarriage.
Collapse
Affiliation(s)
- R J Kuon
- Department of Gynecological Endocrinology and Fertility Disorders, Ruprecht-Karls University Heidelberg, Im Neuenheimer Feld 440, 69120 Heidelberg, Germany
| | - R Togawa
- Department of Gynecological Endocrinology and Fertility Disorders, Ruprecht-Karls University Heidelberg, Im Neuenheimer Feld 440, 69120 Heidelberg, Germany
| | - K Vomstein
- Department of Gynecological Endocrinology and Fertility Disorders, Ruprecht-Karls University Heidelberg, Im Neuenheimer Feld 440, 69120 Heidelberg, Germany
| | - M Weber
- Placenta-Lab, Department of Obstetrics, University Hospital Jena, Am Klinikum 1, 07747 Jena, Germany
| | - T Goeggl
- Department of Gynecological Endocrinology and Fertility Disorders, Ruprecht-Karls University Heidelberg, Im Neuenheimer Feld 440, 69120 Heidelberg, Germany
| | - T Strowitzki
- Department of Gynecological Endocrinology and Fertility Disorders, Ruprecht-Karls University Heidelberg, Im Neuenheimer Feld 440, 69120 Heidelberg, Germany
| | - U R Markert
- Placenta-Lab, Department of Obstetrics, University Hospital Jena, Am Klinikum 1, 07747 Jena, Germany
| | - S Zimmermann
- Department of Infectious Diseases, Medical Microbiology and Hygiene, Ruprecht-Karls University Heidelberg, Im Neuenheimer Feld 324, 69120 Heidelberg, Germany
| | - V Daniel
- Transplantation-Immunology, Institute of Immunology, Ruprecht-Karls University Heidelberg, Im Neuenheimer Feld 672, 69120 Heidelberg, Germany
| | - A H Dalpke
- Department of Infectious Diseases, Medical Microbiology and Hygiene, Ruprecht-Karls University Heidelberg, Im Neuenheimer Feld 324, 69120 Heidelberg, Germany
| | - B Toth
- Department of Gynecological Endocrinology and Reproductive Medicine, Medical University Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria.
| |
Collapse
|
15
|
Michl R, Mues S, Mainz J, Markert U. Hereditäre Stoffwechselerkrankungen – Schwangerschaft bei Mukoviszidose – ein Überblick. Geburtshilfe Frauenheilkd 2017. [DOI: 10.1055/s-0042-114422] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
16
|
Foster BP, Balassa T, Benen TD, Dominovic M, Elmadjian GK, Florova V, Fransolet MD, Kestlerova A, Kmiecik G, Kostadinova IA, Kyvelidou C, Meggyes M, Mincheva MN, Moro L, Pastuschek J, Spoldi V, Wandernoth P, Weber M, Toth B, Markert UR. Extracellular vesicles in blood, milk and body fluids of the female and male urogenital tract and with special regard to reproduction. Crit Rev Clin Lab Sci 2016; 53:379-95. [PMID: 27191915 DOI: 10.1080/10408363.2016.1190682] [Citation(s) in RCA: 49] [Impact Index Per Article: 6.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/09/2023]
Abstract
Extracellular vesicles (EVs) are released from almost all cells and tissues. They are able to transport substances (e.g. proteins, RNA or DNA) at higher concentrations than in their environment and may adhere in a receptor-controlled manner to specific cells or tissues in order to release their content into the respective target structure. Blood contains high concentrations of EVs mainly derived from platelets, and, at a smaller amount, from erythrocytes. The female and male reproductive tracts produce EVs which may be associated with fertility or infertility and are released into body fluids and mucosas of the urogenital organs. In this review, the currently relevant detection methods are presented and critically compared. During pregnancy, placenta-derived EVs are dynamically detectable in peripheral blood with changing profiles depending upon progress of pregnancy and different pregnancy-associated pathologies, such as preeclampsia. EVs offer novel non-invasive diagnostic tools which may reflect the situation of the placenta and the foetus. EVs in urine have the potential of reflecting urogenital diseases including cancers of the neighbouring organs. Several methods for detection, quantification and phenotyping of EVs have been established, which include electron microscopy, flow cytometry, ELISA-like methods, Western blotting and analyses based on Brownian motion. This review article summarises the current knowledge about EVs in blood and cord blood, in the different compartments of the male and female reproductive tracts, in trophoblast cells from normal and pre-eclamptic pregnancies, in placenta ex vivo perfusate, in the amniotic fluid, and in breast milk, as well as their potential effects on natural killer cells as possible targets.
Collapse
Affiliation(s)
- B P Foster
- a Maternal and Fetal Health Research Centre, School of Biomedicine, University of Manchester, and Manchester Academic Health Sciences Centre, University Research , Manchester , UK
| | - T Balassa
- b Department of Medical Microbiology and Immunology , Medical School, University of Pécs , Pécs , Hungary
| | - T D Benen
- c Microtrac GmbH , Krefeld , Germany
| | - M Dominovic
- d Department of Physiology and Immunology , Medical Faculty, University of Rijeka , Rijeka , Croatia
| | - G K Elmadjian
- e Repro Inova Immunology Laboratory , Sofia , Bulgaria
| | - V Florova
- f Department of Obstetrics , Gynecology and Perinatology, First Moscow State Medical University , Moscow , Russia
| | - M D Fransolet
- g Laboratory of Tumor and Development Biology , GIGA-R, University of Liège , Liège , Belgium
| | - A Kestlerova
- h Institute of Medical Biochemistry and Laboratory Diagnostics, General University Hospital and First Faculty of Medicine , Charles University Prague , Czech Republic
- i Institute of Biophysics and Informatics, First Faculty of Medicine, Charles University , Prague , Czech Republic
| | - G Kmiecik
- j Centro di Ricerca E. Menni, Fondazione Poliambulanza Istituto Ospedaliero , Brescia , Italy
| | - I A Kostadinova
- k Department of Immunoneuroendocrinology , Institute of Biology and Immunology of Reproduction , Sofia , Bulgaria
| | - C Kyvelidou
- l Department of Biology , University of Crete , Crete , Greece
| | - M Meggyes
- b Department of Medical Microbiology and Immunology , Medical School, University of Pécs , Pécs , Hungary
| | - M N Mincheva
- m Repro Inova Immunology Laboratory , Sofia , Bulgaria
| | - L Moro
- n ISGlobal, Barcelona Centre for International Health Research (CRESIB), Hospital Clínic- Universitat de Barcelona , Barcelona , Spain
- o Department of Obstetrics , Placenta-Lab, University Hospital Jena , Jena , Germany
| | - J Pastuschek
- o Department of Obstetrics , Placenta-Lab, University Hospital Jena , Jena , Germany
| | - V Spoldi
- j Centro di Ricerca E. Menni, Fondazione Poliambulanza Istituto Ospedaliero , Brescia , Italy
| | - P Wandernoth
- p Institute of Anatomy, University Hospital, University Duisburg-Essen , Essen , Germany
| | - M Weber
- o Department of Obstetrics , Placenta-Lab, University Hospital Jena , Jena , Germany
| | - B Toth
- q Department of Gynecological Endocrinology and Fertility Disorders , Ruprecht-Karls University of Heidelberg , Heidelberg , Germany
| | - U R Markert
- o Department of Obstetrics , Placenta-Lab, University Hospital Jena , Jena , Germany
| |
Collapse
|
17
|
Kuon RJ, Vomstein K, Weber M, Müller F, Seitz C, Wallwiener S, Strowitzki T, Schleussner E, Markert UR, Daniel V, Toth B. The "killer cell story" in recurrent miscarriage: Association between activated peripheral lymphocytes and uterine natural killer cells. J Reprod Immunol 2016; 119:9-14. [PMID: 27865124 DOI: 10.1016/j.jri.2016.11.002] [Citation(s) in RCA: 46] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/19/2016] [Revised: 10/27/2016] [Accepted: 11/02/2016] [Indexed: 01/02/2023]
Abstract
Peripheral and uterine NK cells (pNK, uNK) can be distinguished according to their receptor expression. Recent studies indicate an association of elevated pNK and uNK with recurrent miscarriage (RM). This study aimed to analyze pNK and uNK in patients with RM and healthy controls. Out of n=590 RM patients screened according to a standard diagnostic protocol, n=268 couples with ≥3 consecutive RM were identified. Subgroups consisted of n=151 primary RM (pRM), n=85 secondary RM (sRM), n=32 tertiary RM (tRM) and n=42 healthy controls. Finally, n=147 idiopathic RM (iRM) and n=121 non-iRM patients were identified. Peripheral blood levels of CD45+CD3-CD56+CD16+ NK cells were determined in non-pregnant patients and controls in the mid-luteal phase by FACS. In n=129 RM patients a uterine biopsy was taken to evaluate CD56+ NK cells by immunohistochemistry. PRM showed higher absolute pNK than sRM (median/μl (Q1;Q3): 234 (147;306) vs 176 (128;245), p=0.02). Further a trend towards higher pNK percentages in pRM was detected. UNK numbers did not differ between RM subgroups and did not correlate with pNK. However, the rate of highly elevated uNK was increased in iRM compared to non-iRM patients (p=0.04). Further, higher numbers of CD45+CD3-DR+ (p<0.01) and CD45+CD3+CD8+DR+ (p=0.04) peripheral lymphocytes were associated with higher uNK numbers. In conclusion, elevated pNK were present in pRM patients. Although pNK and uNK numbers did not correlate, the association between high CD45+CD3-DR+ and CD45+CD3+CD8+DR+ peripheral lymphocytes and uNK might indicate that activated NK, B and T cells provide cytokines for the differentiation of uNK.
Collapse
Affiliation(s)
- R J Kuon
- Department of Gynecological Endocrinology and Fertility Disorders, Ruprecht-Karls University Heidelberg, Im Neuenheimer Feld 440, 69120 Heidelberg, Germany
| | - K Vomstein
- Department of Gynecological Endocrinology and Fertility Disorders, Ruprecht-Karls University Heidelberg, Im Neuenheimer Feld 440, 69120 Heidelberg, Germany
| | - M Weber
- Placenta-Lab, Department of Obstetrics, University Hospital Jena, Bachstrasse 18, 07743 Jena, Germany
| | - F Müller
- Department of Gynecological Endocrinology and Fertility Disorders, Ruprecht-Karls University Heidelberg, Im Neuenheimer Feld 440, 69120 Heidelberg, Germany
| | - C Seitz
- Department of Neonatology, Ruprecht-Karls University Heidelberg, Im Neuenheimer Feld 430, 69120 Heidelberg, Germany
| | - S Wallwiener
- Department of Obstetrics and Gynecology, Ruprecht-Karls University Heidelberg, Im Neuenheimer Feld 440, 69120 Heidelberg, Germany
| | - T Strowitzki
- Department of Gynecological Endocrinology and Fertility Disorders, Ruprecht-Karls University Heidelberg, Im Neuenheimer Feld 440, 69120 Heidelberg, Germany
| | - E Schleussner
- Department of Obstetrics and Gynecology, University Hospital Jena, Bachstrasse 18, 07743 Jena, Germany
| | - U R Markert
- Placenta-Lab, Department of Obstetrics, University Hospital Jena, Bachstrasse 18, 07743 Jena, Germany
| | - V Daniel
- Transplantation-Immunology, Institute of Immunology, Ruprecht-Karls University Heidelberg, Im Neuenheimer Feld 672, 69120 Heidelberg, Germany
| | - B Toth
- Gynecological Endocrinology and Reproductive Medicine, Medical University Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria.
| |
Collapse
|
18
|
Göhner C, Fledderus J, Fitzgerald JS, Weber M, Schleußner E, Markert UR, Scherjon SS, Plösch T, Faas MM. Synzytiotrophoblastäre extrazelluläre Vesikel aus gesunden und präeklamptischen Plazenten induzieren Monozyten- und Granulozytenaktivierung. Geburtshilfe Frauenheilkd 2016. [DOI: 10.1055/s-0036-1593239] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
19
|
Heger J, Fröhlich K, Avemag S, Schmidt A, Mrowka R, Groten T, Markert UR, Schleußner E. Toxikologische Analysen an plazentarem Gewebe: Der Einfluss von Chemotherapeutika auf Trophoblastzellen. Geburtshilfe Frauenheilkd 2016. [DOI: 10.1055/s-0036-1592682] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
20
|
Weber M, Toth B, Santillan I, Schleußner E, Markert UR. Immunohistochemical analysis of CD56-positive uNK-cells in the endometrium. Geburtshilfe Frauenheilkd 2016. [DOI: 10.1055/s-0036-1592766] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
21
|
Göhner C, Fitzgerald JS, Fledderus J, Weber M, Schleußner E, Markert UR, Faas MM, Plösch T, Scherjon SS. Synzytiotrophoblastäre extrazelluläre Vesikel induzieren einen toleranten Phänotyp in Lymphozyten. Geburtshilfe Frauenheilkd 2016. [DOI: 10.1055/s-0036-1593036] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
22
|
Kuon R, Müller F, Vomstein K, Weber M, Markert U, Strowitzki T, Daniel V, Toth B. First steps towards a targeted immunomodulatory therapy in patients with recurrent miscarriage and elevated natural killer cells. Geburtshilfe Frauenheilkd 2016. [DOI: 10.1055/s-0036-1593086] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
23
|
Pastuschek J, Butans A, Remane D, Peters FT, Markert UR, Schleußner E, Groten T. Kontinuierlicher transplazentarer Übertritt von Ampicillin und Cefotaxim. Geburtshilfe Frauenheilkd 2016. [DOI: 10.1055/s-0036-1593252] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
24
|
Weber M, Toth B, Schleußner E, Markert UR. Immunohistochemical analysis of CD138-positive Plasma cells in the endometrium. Geburtshilfe Frauenheilkd 2016. [DOI: 10.1055/s-0036-1583573] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022] Open
|
25
|
Fröhlich K, Schmidt A, Heger J, Markert UR. Auswirkungen von Chemotherapeutika auf die Plazenta. Geburtshilfe Frauenheilkd 2016. [DOI: 10.1055/s-0036-1583586] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022] Open
|
26
|
Hutter S, Morales-Prieto DM, Andergassen U, Tschakert L, Kuhn C, Hoffmann S, Markert UR, Jeschke U. Gal-1 silenced trophoblast tumour cells (BeWo) show decreased syncytium formation and different miRNA production compared to non-target silenced BeWo cells. Z Geburtshilfe Neonatol 2015. [DOI: 10.1055/s-0035-1566681] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
27
|
Pastuschek J, Butans A, Rudolph W, Peters FT, Markert UR, Schleussner E, Groten T. Der kontinuierliche transplazentare Übertritt von Ampicillin und Cefotaxim. Z Geburtshilfe Neonatol 2015. [DOI: 10.1055/s-0035-1566571] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
28
|
Weber M, Toth B, Schleußner E, Markert UR. Immunhistochemische Analyse von CD56 positiven uNK-Zellen im Endometrium. Geburtshilfe Frauenheilkd 2015. [DOI: 10.1055/s-0035-1551644] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
29
|
Michl RK, Mues S, Mainz JG, Markert UR. [Pregnancy and cystic fibrosis - an overview]. Z Geburtshilfe Neonatol 2015; 219:170-5. [PMID: 26039502 DOI: 10.1055/s-0035-1545341] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Abstract
Life expectancy and quality of life of cystic fibrosis (CF) patients have been steadily increasing for many decades, due to intensified therapy and research. Correspondingly, the number of pregnancies in women with CF rises. Often it is not possible for the patients to assess the consequences of pregnancy in terms of their disease and the impact of their disease on the growing child. A pre-existing poor lung function, low body mass index, CF-related diabetes, chronic microbial colonisation, and transplanted lungs are the main risk factors for complications during pregnancy in CF. Generally, the best outcome for mother and child can be reached under exact planning and meshed multidisciplinary care. The purpose of this summary is to give a practical review of the risks and options associated with pregnancy in CF patients.
Collapse
Affiliation(s)
- R K Michl
- Mukoviszidoszentrum für Kinder und Erwachsene, Klinik für Kinderheilkunde und Jugendmedizin, Univeritätsklinikum Jena, Jena
| | - S Mues
- Abteilung für Geburtshilfe, Universitätsklinikum Jena, Jena
| | - J G Mainz
- Mukoviszidoszentrum für Kinder und Erwachsene, Klinik für Kinderheilkunde und Jugendmedizin, Univeritätsklinikum Jena, Jena
| | - U R Markert
- Abteilung für Geburtshilfe, Universitätsklinikum Jena, Jena
| |
Collapse
|
30
|
Schönleben M, Morales Prieto D, Markert U, Schleußner E, Groten T. Assoziation des miRNA Cluster 371 – 3 mit der Trophoblastmigration. Geburtshilfe Frauenheilkd 2015. [DOI: 10.1055/s-0035-1548712] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
31
|
Weber M, Yan Y, Knöfler I, Schleussner E, Markert U, Fitzgerald JS. Lösliche plazentare Signale regulieren über den Chemokinrezeptor 1 und 3 die schnelle und gerichtete Migration Trophoblaststammzell-ähnlicher Populationen an gestressten Plazentaarealen. Geburtshilfe Frauenheilkd 2014. [DOI: 10.1055/s-0034-1388251] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
|
32
|
Weber M, Jeschke U, Schleussner E, Markert U, Fitzgerald JS. Das Expressionsprofil der trophoblastären und embryonalen Stammzellmarker unterscheidet sich nach Schwangerschaftsalter und -pathologie. Geburtshilfe Frauenheilkd 2014. [DOI: 10.1055/s-0034-1388103] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
|
33
|
Weichold A, Markert U, Schleußner E, Groten T. N-Cadherin und CD162 vermitteln die spezifische Interaktion zwischen Trophoblastzellen und endothelialen Tubuli. Geburtshilfe Frauenheilkd 2014. [DOI: 10.1055/s-0034-1388027] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
|
34
|
Schönleben M, Markert U, Morales Prieto D, Schleußner E, Groten T. Assoziation des mi RNA Cluster 371-3 mit der Trophoblastmigration. Geburtshilfe Frauenheilkd 2014. [DOI: 10.1055/s-0034-1388064] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
|
35
|
Göhner C, Markert UR, Schleußner E, Bräuer R. Nanopartikel in der Plazenta – Detektion und Wirkung. Geburtshilfe Frauenheilkd 2014. [DOI: 10.1055/s-0034-1388250] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
|
36
|
Gohner C, Bonnke C, Sossdorf M, Lösche W, Schleußner E, Markert UR, Fitzgerald JS. Sauerstoffmangel führt zu veränderten Gerinnungseigenschaften synzytiotrophoblastärer Mikropartikel (STBM). Geburtshilfe Frauenheilkd 2014. [DOI: 10.1055/s-0034-1388079] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
|
37
|
Holschbach V, Toth B, Kuon RJ, Goeggl T, Franz C, Strowitzki T, Daniel V, Weber M, Markert U. Keine Korrelation uteriner und peripherer natürlicher Killerzellen bei Patientinnen mit habituellen Aborten und Implantationsversagen. Geburtshilfe Frauenheilkd 2014. [DOI: 10.1055/s-0034-1387967] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
|
38
|
Rossmann C, Hammer A, Koyani CN, Kovacevic A, Siwetz M, Desoye G, Poehlmann TG, Markert UR, Huppertz B, Sattler W, Malle E. Expression of serum amyloid A4 in human trophoblast-like choriocarcinoma cell lines and human first trimester/term trophoblast cells. Placenta 2014; 35:661-4. [PMID: 24951172 PMCID: PMC4119475 DOI: 10.1016/j.placenta.2014.05.012] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/19/2014] [Revised: 05/27/2014] [Accepted: 05/29/2014] [Indexed: 11/16/2022]
Abstract
Trophoblast invasion into uterine tissues represents a hallmark of first trimester placental development. As expression of serum amyloid A4 (SAA4) occurs in tumorigenic and invasive tissues we here investigated whether SAA4 is present in trophoblast-like human AC1-M59/Jeg-3 cells and trophoblast preparations of human first trimester and term placenta. SAA4 mRNA was expressed in non-stimulated and cytokine-treated AC1-M59/Jeg-3 cells. In purified trophoblast cells SAA4 mRNA expression was upregulated at weeks 10 and 12 of pregnancy. Western-blot and immunohistochemical staining of first trimester placental tissue revealed pronounced SAA4 expression in invasive trophoblast cells indicating a potential role of SAA4 during invasion. SAA4 mRNA is expressed in Jeg-3 and AC1-M59 cells. SAA4 mRNA is expressed in first trimester/term trophoblast cells. SAA4 mRNA is upregulated at pregnancy week 10 and 12. SAA4 protein is present in interstitial, intramural and intraluminal trophoblast cells.
Collapse
Affiliation(s)
- C Rossmann
- Medical University of Graz, Institute of Molecular Biology and Biochemistry, Graz A-8010, Austria
| | - A Hammer
- Medical University of Graz, Institute of Cell Biology, Histology and Embryology, Graz, Austria
| | - C N Koyani
- Medical University of Graz, Institute of Molecular Biology and Biochemistry, Graz A-8010, Austria
| | - A Kovacevic
- Medical University of Graz, Institute of Molecular Biology and Biochemistry, Graz A-8010, Austria
| | - M Siwetz
- Medical University of Graz, Institute of Cell Biology, Histology and Embryology, Graz, Austria
| | - G Desoye
- Medical University of Graz, Department of Obstetrics and Gynecology, Graz, Austria
| | - T G Poehlmann
- Placenta-Laboratory, Department of Obstetrics, University Hospital Jena, Jena, Germany
| | - U R Markert
- Placenta-Laboratory, Department of Obstetrics, University Hospital Jena, Jena, Germany
| | - B Huppertz
- Medical University of Graz, Institute of Cell Biology, Histology and Embryology, Graz, Austria
| | - W Sattler
- Medical University of Graz, Institute of Molecular Biology and Biochemistry, Graz A-8010, Austria
| | - E Malle
- Medical University of Graz, Institute of Molecular Biology and Biochemistry, Graz A-8010, Austria.
| |
Collapse
|
39
|
Morales-Prieto DM, Ospina-Prieto S, Schmidt A, Chaiwangyen W, Markert UR. Elsevier Trophoblast Research Award Lecture: origin, evolution and future of placenta miRNAs. Placenta 2013; 35 Suppl:S39-45. [PMID: 24378039 DOI: 10.1016/j.placenta.2013.11.017] [Citation(s) in RCA: 57] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/11/2013] [Revised: 11/25/2013] [Accepted: 11/25/2013] [Indexed: 01/01/2023]
Abstract
MicroRNAs (miRNAs) regulate the expression of a large number of genes in plants and animals. Placental miRNAs appeared late in evolution and can be found only in mammals. Nevertheless, these miRNAs are constantly under evolutionary pressure. As a consequence, miRNA sequences and their mRNA targets may differ between species, and some miRNAs can only be found in humans. Their expression can be tissue- or cell-specific and can vary time-dependently. Human placenta tissue exhibits a specific miRNA expression pattern that dynamically changes during pregnancy and is reflected in the maternal plasma. Some placental miRNAs are involved in or associated with major pregnancy disorders, such as preeclampsia, intrauterine growth restriction or preterm delivery and, therefore, have a strong potential for usage as sensitive and specific biomarkers. In this review we summarize current knowledge on the origin of placental miRNAs, their expression in humans with special regard to trophoblast cells, interspecies differences, and their future as biomarkers. It can be concluded that animal models for human reproduction have a different panel of miRNAs and targets, and can only partly reflect or predict the situation in humans.
Collapse
Affiliation(s)
- D M Morales-Prieto
- University Hospital Jena, Department of Obstetrics, Placenta-Lab, Bachstraße. 18, 07743 Jena, Germany.
| | - S Ospina-Prieto
- University Hospital Jena, Department of Obstetrics, Placenta-Lab, Bachstraße. 18, 07743 Jena, Germany
| | - A Schmidt
- University Hospital Jena, Department of Obstetrics, Placenta-Lab, Bachstraße. 18, 07743 Jena, Germany
| | - W Chaiwangyen
- University Hospital Jena, Department of Obstetrics, Placenta-Lab, Bachstraße. 18, 07743 Jena, Germany
| | - U R Markert
- University Hospital Jena, Department of Obstetrics, Placenta-Lab, Bachstraße. 18, 07743 Jena, Germany
| |
Collapse
|
40
|
Weber M, Jeschke U, Markert UR, Fitzgerald JS. Differential expression of trophoblast-, endothelial- and embryonic-stem-cell-associated transcription factors in 1st trimester, and 3rd trimester preeclampsia (PE), intrauterine growth factor (IUGR) and control placentae. Z Geburtshilfe Neonatol 2013. [DOI: 10.1055/s-0033-1361385] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
41
|
Weber M, Knoefler I, Schleußner E, Markert UR, Fitzgerald JS. HTR8/SVneo, but not JEG3, cells display trophoblast progenitor cell-like characteristics indicative of self-renewal, repopulation activity and expression of “stemness”- associated transcription factors. Z Geburtshilfe Neonatol 2013. [DOI: 10.1055/s-0033-1361402] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
42
|
Chaiwangyen W, Morales-Prieto DM, Ospina-Prieto S, Schleußner E, Markert UR. Silencing of miR-21 regulates proliferation and invasion in trophoblastic cells and targets PTEN. Z Geburtshilfe Neonatol 2013. [DOI: 10.1055/s-0033-1361420] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
43
|
Göhner C, Bräuer R, Kadyrov M, Markert UR, Schleußner E. Investigations of the influence of diverse nano-particles towards the placental tissue in the frame of the NanoMed project. Z Geburtshilfe Neonatol 2013. [DOI: 10.1055/s-0033-1361438] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
44
|
Fitzgerald JS, Groten T, Göhner C, Sargent I, Sossdorf M, Lösche W, Markert UR, Schleußner E. Preliminary results of the MORE PrePARd Study (Microparticle Orientated Risk Evaluation in the Prediction of Preeclampsia Among Risk graviDas): a multicenter prospective prognostic marker study. Z Geburtshilfe Neonatol 2013. [DOI: 10.1055/s-0033-1361252] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
45
|
Göhner C, Bonnke C, Sossdorf M, Lösche W, Schleußner E, Markert UR, Fitzgerald JS. Hypoxia alters syncytiotrophoblastic microparticles (STBM)-related coagulation capacities. Z Geburtshilfe Neonatol 2013. [DOI: 10.1055/s-0033-1361381] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
46
|
Pestka A, Fitzgerald J, Toth B, Markert U, Jeschke U. Nuclear Hormone Receptors and Female Reproduction. Curr Mol Med 2013; 13:1066-78. [DOI: 10.2174/1566524011313070002] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/15/2012] [Revised: 10/21/2012] [Accepted: 10/26/2012] [Indexed: 11/22/2022]
|
47
|
San Martin S, Fitzgerald JS, Weber M, Párraga M, Sáez T, Zorn TM, Markert UR. Stat3 and Socs3 expression patterns during murine placenta development. Eur J Histochem 2013; 57:e19. [PMID: 23807298 PMCID: PMC3794345 DOI: 10.4081/ejh.2013.e19] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/10/2013] [Revised: 04/22/2013] [Accepted: 04/23/2013] [Indexed: 11/25/2022] Open
Abstract
Signal transducers and activators of transcription 3 (STAT3) has been identified as an important signal transducer in the invasive phenotype of the trophoblasts cells in in vitro studies. However, the in situ distribution and patterns of expression of this molecule in trophoblast cells during the development of the placenta are still under-elucidated. Mice uteri of gestational ages between 7 and 14 days of pregnancy (dop) were fixed in methacarn and processed with immunoperoxidase techniques for detection of STAT3 and its phosphorylation at serine (p-ser727) residues, as well as the suppressor of cytokine signaling 3 (SOCS3) expression. STAT3 was observed at 7 through 9 dop in both the antimesometrial and mesometrial deciduas, while continued immunoreactivity between 10 and 13 dop was seen only in the mesometrial decidua. In the placenta, STAT3 was detected in the cytotrophoblast cells of labyrinth and giant trophoblast cells between 10 and 14 dop. Immunoreactivity for STAT3 was also seen in trophoblast cells surrounding the maternal blood vessels. On days 10 and 11 of pregnancy, p-ser727 was detectable in the mesometrial decidua and in giant trophoblasts, while during 12-14 dop in the spongiotrophoblast region. In addition, SOCS3 was immunodetected in maternal and placental tissues, principally in the giant trophoblast cells during the whole period of the study. The present in situ study shows the distribution of STAT3, its serine activation and SOCS3 in different maternal and fetal compartments during murine placental development, thus further supporting the idea that they play a role during physiological placentation in mice.
Collapse
Affiliation(s)
- S San Martin
- Biomedical Research Centre, School of Medicine, Universidad de Valparaiso, Chile.
| | | | | | | | | | | | | |
Collapse
|
48
|
Groten T, Weichold A, Markert U, Reister F, Huppertz B, Schleußner E. Identifizierung von diskriminierend exprimierter Adhäsionsmoleküle, die in der Ko-Kultur eine charakteristische Interaktion von HTR-8 Zellen (extravillöse Trophoblastzellen) mit Endothelzellen vermitteln. Geburtshilfe Frauenheilkd 2013. [DOI: 10.1055/s-0033-1347718] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022] Open
|
49
|
Göhner C, Bonnke C, Sossdorf M, Lösche W, Schleußner E, Markert UR, Fitzgerald J. Hypoxia alters syncytiotrophoblastic microparticles (STBM)-related coagulation capacities. Geburtshilfe Frauenheilkd 2013. [DOI: 10.1055/s-0033-1347732] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022] Open
|
50
|
Weber M, Jeschke U, Schleussner E, Markert UR, Fitzgerald JS. Differential expression of trophoblast-, endothelial- and embryonic-stem-cell-associated transcription factors in 1st trimester, and 3 rd trimester preeclampsia (PE), intrauterine growth factor (IUGR) and control placentae. Geburtshilfe Frauenheilkd 2013. [DOI: 10.1055/s-0033-1347735] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022] Open
|